abstract aspects of the invention provide methods for treatment of nonalcoholic steatohepatitis and associated liver fibrosis. in particular, aspects of the invention report to the use of a therapeutic formulation comprising a galacto-rhamnogalacturonate compound for the treatment of nonalcoholic steatohepatitis and associated liver fibrosis. ___________________________________________________________________________ translation summary summary patent: "galacto-rhamnogalacturonate compositions for the treatment of non-alcoholic steatohepatitis and non-alcoholic liver fat disease". aspects of the invention provide methods for treating nonalcoholic steatohepatitis and associated liver fibrosis. in particular, aspects of the invention relate to the use of a therapeutic formulation comprising a galacto-rhamnogalacturonate compound for the treatment of nonalcoholic steatohepatitis and associated liver fibrosis.abstract aspects of the invention provide methods for treatment of nonalcoholic steatohepatitis and associated liver fibrosis. in particular, aspects of the invention relate to the use of a therapeutic formulation comprising a galacto-rhamnogalacturonate compound for the treatment of nonalcoholic steatohepatitis and associated liver fibrosis. ___________________________________________________________________________ tradução resumo resumo patente de invenção: "composições de galacto-ramnogalacturonato para o tratamento de esteatohepatite não alcoólica e de doença de gordura no fígado não alcoólica". os aspectos da invenção apresentam métodos para o tratamento do esteatohepatite não alcoólica e de fibrose do fígado associada. em particular, os aspectos da invenção referem-se ao uso de uma formulação terapêutica que compreende um composto de galacto-ramnogalacturonato para o tratamento da esteatohepatite não alcoólica e da fibrose do fígado associada.
